Although leishmaniasis is a major tropical disease, the currently available drugs are toxic and inadequate.
Leishmaniasis is a major tropical disease affecting 12 million people (33) . Pentavalent antimonial agents and pentamidine have been the recommended treatment for this disease since the second world war (8) . However, they cause severe adverse side effects and failure of treatment is not uncommon; therefore, better, less toxic therapeutic drugs are urgently needed. We discovered that trifluralin and oryzalin, antimicrotubule dinitroaniline herbicides, inhibit leishmania proliferation and infectivity (4) (5) (6) (7) . Moreover, in addition to being effective against Leishmania spp., trifluralin is effective against the in vitro proliferation of Trypanosoma brucei trypomastigotes (6, 14) and the intraerythrocytic forms of the malaria parasite Plasmodium falciparum (22) . Thus, trifluralin is effective against several species of protozoan parasites.
Trifluralin and oryzalin belong to a class of compounds known as the dinitroanilines ( Fig. 1 and Table 1 ). As herbicides, the dinitroanilines cause multinucleation, accumulation of cells at the metaphase, and the loss of microtubules from root cells. They bind to plant but not animal tubulins. Trifluralin and many of its analogs have been commercially available since the 1960s and have been widely used for weed control on lands with fruit trees and vegetable crops. Trifluralin and related compounds are inexpensive to manufacture, and their traits are well characterized, including their toxicities and shelf-lives. In its purified form, trifluralin is generally shown to be noncarcinogenic, nonteratogenic, and nonmutagenic, as shown by various standard in vitro mutagenic studies and in vivo genotoxicity assays with bacteria, yeasts, mammalian cells, and animals (1, 9, 11, 12, 18, 24, 34) . Thus, this group of herbicides includes promising lead compounds for antiparasitic agents. Moreover, they may be economical for the treatment of the domestic animal reservoirs that play a major role in the epidemiology of parasitic diseases (such as dogs for leishmaniasis in some countries [see references 15 and 25] ).
To pursue the goal of developing dinitroanilines for leish-Promastigote assay. Dinitroanilines were dissolved according to the following protocol. The compounds were first dissolved in acetone as a 100 mM solution. Then they were diluted in 0.1% acetone-liver infusion tryptose (27) medium that had been prewarmed to 65°C. Solutions of 1 mM (1/100 dilution) and 0.5 mM (1/2 dilution) were made from the acetone stocks and then were made to the final concentrations by using 10-fold serial dilutions. 02320, 10870, and 91650). Thus, we suspected the presence of impurities in the herbicide samples.
Impurities in the dinitroaniline compounds. Gas chromatography analysis showed that the more potent trifluralin samples contained impurities ( Fig. 2A and B) . By quantitative analysis, the largest impurity peak constituted approximately 0.6% of the trifluralin peak. In addition, two other Dow Elanco compounds, benfluralin and ethalfluralin, also had the same minor impurity peaks (data not shown) and their ED50s, 6.6 and 7.6 p,M, respectively, were similar to that of trifluralin with the contaminant. Fluchloralin from Riedel-de Haen, the ED50 of which was comparable to those of the compounds from Dow Elanco (4 ,tM), also had similar impurity peaks (Table 2 and Fig. 2C) . Thus, the importance of these impurities was emphasized.
Active structures. We attempted to deduce the structurefunction relationship of analogs against L. mexicana. Comparisons were made among the analogs which did not contain the impurities. The results indicated that higher efficacy was associated with an increase in the level of accessibility to the nitro group; access to either one of the two nitro groups was sufficient.
Pendimethalin (ED5O, 5.6 p,M), with a hydrogen instead of a propyl group (at the R3 position; see Table 1 ), was more effective than trifluralin from Riedel-de Haen (ED50, 14.2 ,uM) and had an efficacy comparable to that of the compound from Dow Elanco (ED50, 4.6 pM). On the other hand, benfluralin, with an extra carbon at the R3 position, was ineffective (ED50, >50 ,M). Correspondingly, profluralin, with a cyclopropylmethyl group that is similar in size to the propyl group of trifluralin, was similar in efficacy (EDSO, 11.2 p,M) to trifluralin. Apparently, a hydrophobic region of maximum volume corresponding to a propyl group at R2 or R3 is required. This interpretation was further supported by the findings with prodiamine and dinitramine. With prodiamine, an amino group at R4 decreased the hydrophobicity The structures of the trifluralin analogs were approximated by molecular mechanics, using the Insight II molecular modeling package. The models show that the dialkylsubstituted amino and, possibly, the o-nitro groups must rotate out of the plane of the benzene ring. Even though the exact positions await crystallographic analysis, the molecular structures of these compounds in the immediate vicinity of the central benzene ring are so compact and constrained sterically that only minor variations from predicted molecular structures are likely. From the models presented in Fig.  3 , the accessibility of the nitro groups can be estimated. In comparison with trifluralin, one of the nitro groups of pendimethalin is more accessible, whereas the hydrophobic region of prodiamine is reduced by the presence of an amino group at R4. Comparing prodiamine and dinitramine, the ethyl groups in dinitramine are replaced by the propyl groups in prodiamine, which appears to be a positive effect, compensating for the negative effects of the amino group at the R4 position. Comparing trifluralin and benfluralin, at the R3 position, the propyl group of trifluralin yields an effective compound, whereas the bulkier butyl group of benfluralin does not.
In addition, we found that substitution of a sulfonyl group for a trifluoromethyl group at Rl, an alternate method of decreasing the hydrophobicity of the molecule, caused the compounds to be less effective. Nitralin (ED50, 23.4 ,uM) was 1.6-fold less effective than trifluralin (ED50, 14.2 ,uM) ( Table 2) .
DISCUSSION
In our attempt to determine the crucial chemical structures needed for leishmania inhibition, we compared the efficacies of different trifluralin analogs and found that trifluralin from different sources varied in ED50. Gas chromatography analysis showed that the more potent preparations contained impurities. Since trifluralin is a photolabile compound, the impurities may be photodegraded products or they may be synthesis by-products (18, 32) . We are in the process of isolating the impurities from trifluralin so that the antileishmania activity of the impurity may be assessed directly.
Comparing the efficacies of different trifluralin analogs, we also found that the increase in efficacy correlated with the accessibility of one of the nitro groups and to the presence of a hydrophobic region of specific volume. Molecular modeling of the analogs supported this conclusion drawn from the experimental results. Pendimethalin was more effective than trifluralin against L. mexicana and was not inhibitory to human monocytes. Moreover, this increase in efficacy was not associated with an increase in toxicity for mammalian cells. As with trifluralin (5), no significant inhibition of proliferation was observed at a concentration that was 12.5-fold greater than the effective dose for the parasites (data not shown).
The action of dinitroanilines on plants and protozoans may be due to similarities among their tubulin proteins (10, 30) . Silflow (29) has discussed the fact that the ciliate and flagellate protozoans seem to lack diversity in their tubulins and suggested that the reason may be the stringent and constrained requirements for the axoneme structure of these unicellular organisms. This is an interesting point for contemplation. However, many multicellular organisms also have cells with cilia and flagella.
Experiments performed by us and others have indicated that dinitroanilines are active against several groups of protozoans, namely, the flagellates, the ciliates, and the apicomplexans. For the flagellates, oryzalin inhibits leishmania differentiation and in vitro microtubule polymerization of Leishmania tubulin (7) . Trifluralin binds Leishmania tubulin and inhibits Leishmania differentiation; it also binds Chlamydomonas flagellar tubulin and inhibits flagellar regeneration of C eugametos (5, 16, 17) . Trifluralin even modulates the chemosensory response of the dinoflagellate Crypthecondinium cohnii (20) . For the ciliates, trifluralin inhibits microtubule-based oral structure regeneration of Stentor coeruleus; it inhibits cell division of Paramecium tetraurelia (3, 23) . Oryzalin even increases a-tubulin mRNA transcription of Tetrahymena thermophila (31) . For the apicomplexans, trifluralin inhibits both the growth and the differentiation of P. falciparum, especially at the exflagellation stage (22 For the parasitic protozoan L. mexicana, targeting of drugs at unique organelles such as the kinetoplast and glycosomes has been suggested (13) . Our data, as presented here, have demonstrated that microtubules are also promising targets. Drugs with microtubules as their targets have previously been used successfully, notably, the antihelminthic benzimidazoles and the anticancer compounds such as vinblastine, vincristine, and taxol (19, 26, 28 
